Public Employees Retirement System of Ohio lessened its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 3.9% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 40,218 shares of the insurance provider’s stock after selling 1,648 shares during the period. Public Employees Retirement System of Ohio’s holdings in Humana were worth $6,973,000 at the end of the most recent reporting period.
Other institutional investors have also bought and sold shares of the company. Montag A & Associates Inc. grew its holdings in Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the period. CoreCap Advisors LLC lifted its stake in shares of Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares during the period. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana during the 4th quarter valued at about $27,000. Reflection Asset Management bought a new stake in shares of Humana during the 4th quarter valued at about $29,000. Finally, Larson Financial Group LLC grew its stake in Humana by 114.1% during the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after purchasing an additional 81 shares during the period. Institutional investors own 92.38% of the company’s stock.
Humana Stock Up 1.8%
Shares of NYSE:HUM opened at $388.09 on Wednesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The business’s 50 day simple moving average is $367.16 and its two-hundred day simple moving average is $266.44. The firm has a market cap of $46.59 billion, a P/E ratio of 41.51, a PEG ratio of 2.07 and a beta of 0.71.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on HUM shares. Royal Bank Of Canada lifted their target price on Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a report on Thursday, July 9th. Wolfe Research raised shares of Humana from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. Mizuho lifted their price objective on shares of Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. Robert W. Baird dropped their target price on shares of Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, May 20th. Two investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, fifteen have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $327.17.
Get Our Latest Report on Humana
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
